We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
NCR Voyix
VYX
$1.19B
| $12.9M | 0.03% |
460,561
+15,542
| +3% | +$426K |
|
552
Lear
LEA
$7.39B
| $12.9M | 0.03% |
91,141
+3,658
| +4% | +$519K |
|
|
ACC
553
DELISTED
American Campus Communities, Inc.
ACC
| $12.8M | 0.03% |
269,846
+19,313
| +8% | +$943K |
|
554
TechnipFMC
FTI
$28.6B
| $12.8M | 0.03% |
529,064
+10,268
| +2% | +$253K |
|
555
Pultegroup
PHM
$25.2B
| $12.7M | 0.03% |
539,111
+11,144
| +2% | +$240K |
|
556
AES
AES
$10.6B
| $12.5M | 0.03% |
1,119,769
+16,788
| +2% | +$192K |
|
557
Brunswick
BC
$5.23B
| $12.5M | 0.03% |
204,070
+6,474
| +3% | +$383K |
|
558
Hilton Worldwide
HLT
$72.4B
| $12.5M | 0.03% |
213,564
+19,190
| +10% | +$1.11M |
|
559
JetBlue
JBLU
$2.16B
| $12.4M | 0.03% |
602,502
+36,536
| +6% | +$745K |
|
|
MSCC
560
DELISTED
Microsemi Corp
MSCC
| $12.4M | 0.03% |
240,625
+6,969
| +3% | +$374K |
|
561
Fidelity National Financial
FNF
$14.4B
| $12.4M | 0.03% |
458,116
+25,136
| +6% | +$640K |
|
562
Leggett & Platt
LEG
$1.4B
| $12.3M | 0.03% |
244,741
+6,638
| +3% | +$324K |
|
563
Essential Utilities
WTRG
$11.5B
| $12.3M | 0.03% |
381,817
+16,939
| +5% | +$520K |
|
564
Fluor
FLR
$6.54B
| $12.3M | 0.03% |
233,193
-1,863
| -0.8% | -$102K |
|
565
AptarGroup
ATR
$8.69B
| $12.3M | 0.03% |
159,291
+34,745
| +28% | +$2.6M |
|
|
VER
566
DELISTED
VEREIT, Inc.
VER
| $12.2M | 0.03% |
288,417
+23,678
| +9% | +$1.02M |
|
567
Flowserve
FLS
$8.94B
| $12.2M | 0.03% |
251,994
+6,503
| +3% | +$315K |
|
|
DISCK
568
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $12.1M | 0.03% |
428,318
+3,340
| +0.8% | +$91.5K |
|
569
RenaissanceRe
RNR
$13.8B
| $12.1M | 0.03% |
83,710
+6,896
| +9% | +$987K |
|
570
Palo Alto Networks
PANW
$256B
| $12.1M | 0.03% |
644,670
+50,934
| +9% | +$1.14M |
|
571
Lamb Weston
LW
$7.42B
| $12.1M | 0.03% |
287,020
+9,356
| +3% | +$369K |
|
572
Sonoco
SON
$5.83B
| $12M | 0.03% |
227,249
-14,137
| -6% | -$761K |
|
573
Keysight
KEYS
$50.7B
| $12M | 0.03% |
332,468
+24,681
| +8% | +$919K |
|
574
Prosperity Bancshares
PB
$8.9B
| $12M | 0.03% |
172,107
+1,232
| +0.7% | +$89.5K |
|
|
LPT
575
DELISTED
Liberty Property Trust
LPT
| $12M | 0.03% |
311,177
+6,749
| +2% | +$264K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.